-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Oncology Institute, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2019 to Q2 2025.
- Oncology Institute, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$11.2M, a 31.5% increase year-over-year.
- Oncology Institute, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$46.9M, a 26.2% increase year-over-year.
- Oncology Institute, Inc. annual Operating Income (Loss) for 2024 was -$60.1M, a 21.9% increase from 2023.
- Oncology Institute, Inc. annual Operating Income (Loss) for 2023 was -$77M, a 6.02% increase from 2022.
- Oncology Institute, Inc. annual Operating Income (Loss) for 2022 was -$82M, a 78.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)